Ryu Watanabe Selected Research

Ryu Watanabe Research Topics

Disease

29	Rheumatoid Arthritis 05/2024 - 01/2013
10	Vasculitis (Vasculitides) 11/2023 - 07/2012
7	Infections 03/2024 - 11/2013
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2023 - 07/2012
7	Takayasu Arteritis (Arteritis, Takayasu's) 01/2022 - 12/2018
6	Giant Cell Arteritis (Horton Disease) 02/2024 - 01/2019
5	Autoimmune Diseases (Autoimmune Disease) 06/2023 - 01/2013
5	Hepatitis B 01/2023 - 11/2013
5	Inflammation (Inflammations) 01/2022 - 03/2016
4	Necrosis 05/2024 - 04/2023
4	Neoplasms (Cancer) 03/2023 - 10/2009
3	Hypertension (High Blood Pressure) 05/2024 - 06/2011
3	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2023 - 01/2016
3	Rheumatic Diseases (Rheumatism) 07/2022 - 01/2014
3	Hyperplasia 01/2019 - 01/2017
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 09/2023 - 08/2023
2	Disease Progression 06/2023 - 01/2020
2	Sarcopenia 04/2023 - 10/2021
2	Osteoporosis 01/2023 - 07/2022
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 03/2016
2	Systemic Scleroderma (Systemic Sclerosis) 01/2016 - 01/2016
2	Hemolytic Anemia 01/2013 - 01/2010
2	Collagen Diseases (Collagen Disease) 01/2013 - 07/2012
1	Churg-Strauss Syndrome (Allergic Angiitis) 05/2024
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2023
1	Atrophy 06/2023
1	Compression Fractures (Compression Fracture) 01/2023
1	Neutropenia 11/2022
1	Lung Diseases (Lung Disease) 03/2022
1	Dysbiosis 01/2022
1	Bone Resorption 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	VEXAS syndrome 01/2022

Drug/Important Bio-Agent (IBA)

8	Antirheumatic Agents (DMARD)IBA 05/2024 - 01/2020
8	tocilizumab (atlizumab)FDA Link 06/2023 - 11/2014
7	Janus Kinase InhibitorsIBA 05/2024 - 01/2018
7	CytokinesIBA 04/2023 - 01/2015
5	AntibodiesIBA 05/2024 - 07/2012
5	Proteins (Proteins, Gene)FDA Link 11/2023 - 07/2012
5	AutoantibodiesIBA 01/2016 - 07/2012
4	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 05/2024 - 01/2022
4	Immunoglobulin G (IgG)IBA 06/2023 - 07/2012
4	EnzymesIBA 01/2022 - 01/2010
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2020 - 11/2013
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 05/2010
3	Methotrexate (Mexate)FDA LinkGeneric 05/2024 - 10/2020
3	Rheumatoid FactorIBA 05/2024 - 01/2020
3	Abatacept (Orencia)FDA Link 01/2024 - 01/2020
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2023 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 04/2023 - 01/2015
3	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 01/2015
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 05/2010
2	GlucocorticoidsIBA 03/2024 - 01/2023
2	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 06/2023
2	C-Reactive ProteinIBA 11/2023 - 12/2021
2	Interleukin-6 InhibitorsIBA 06/2023 - 04/2023
2	AntigensIBA 06/2023 - 01/2020
2	tofacitinibIBA 01/2023 - 01/2018
2	Monoclonal AntibodiesIBA 07/2022 - 01/2018
2	Janus KinasesIBA 01/2022 - 01/2018
2	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2022
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2016
2	HLA-B Antigens (HLA-B)IBA 01/2021 - 12/2018
2	Anti-Citrullinated Protein AntibodiesIBA 11/2020 - 01/2017
2	ametantrone (HAQ)IBA 11/2020 - 01/2016
2	Phenobarbital (Luminal)FDA Link 01/2019 - 01/2017
2	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 03/2016
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2016 - 05/2010
2	CreatinineIBA 01/2015 - 01/2010
2	AutoantigensIBA 10/2013 - 01/2013
2	Leucine (L-Leucine)FDA Link 01/2013 - 07/2012
2	Fibronectins (Fibronectin)IBA 01/2013 - 07/2012
1	mepolizumabIBA 05/2024
1	LDL CholesterolIBA 02/2024
1	Alkaline PhosphataseIBA 12/2023
1	Serum AlbuminIBA 11/2023
1	Peroxidase (Myeloperoxidase)IBA 09/2023
1	HomocysteineIBA 08/2023
1	Polysaccharides (Glycans)IBA 06/2023
1	Immune Checkpoint InhibitorsIBA 03/2023
1	Interleukin-9 (Interleukin 9)IBA 01/2023
1	Denosumab FDA Link 07/2022
1	Immunoglobulin FragmentsIBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Pyruvate KinaseIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	SteroidsIBA 01/2022
1	hydroxide ionIBA 10/2021
1	Vitamin D FDA LinkGeneric 10/2021
1	25-hydroxyvitamin DIBA 10/2021
1	SaltsIBA 01/2021
1	PotassiumIBA 01/2021

Therapy/Procedure

13	Therapeutics 01/2024 - 05/2010
2	Drug Therapy (Chemotherapy) 01/2015 - 01/2014
1	Drug Tapering 03/2024
1	Remission Induction 08/2023
1	Plasma Exchange 08/2023